Author: K.E.D.C.
Sky islands, bird tears, and toxic algal blooms
In 2020, my work for the Frontiers blog has included therapeutic horseback riding, avian brain size and survival tactics, bird and reptile […]
Developments in data, digital tech, and transplantation
Two updates on what Novartis is doing in the field of transplantation and also the status of data and digital technologies (translated […]
Making R&D greener
A story about how Novartis researchers are working towards making R&D more environmentally friendly, including the very early stages of drug development.
A promise to fight sickle cell disease
A story about commitment and follow-through in the fight against sickle cell disease. Read more here.
Medicines and candy wrappers
Candy wrappers are inspiring better packaging for medicines. Read more here.
A digital revolution in pathology
Novartis researchers are collaborating on a digital resource to advance the entire field of pathology. Read more here.
Model brains
Another article in the Basler Zeitung (on page 5, translated into German) about researchers’ work creating miniature replica brains to better understand […]
Collaborations in a microscopy revolution
More articles in the Basler Zeitung about Novartis’s research on migraines (pg. 7), data science and digitalization (pg. 6), and their cutting-edge […]
Pensions, volcanoes, and microbiomes
From the laws of attraction to a musical instrument controlled by thought alone, see my work at the Frontiers blog here. A […]
Revealing what’s not human
Read my short piece on the work of Dr. Joe DeRisi, who was interviewed by Carl Zimmer at the 2017 World Conference […]
Math puzzles that help patients
For the Novartis Live magazine, I profiled biostatistician Amy Racine-Poon, who uses Bayesian statistics to optimize clinical trial design. Read more in […]
Regrowing cartilage and more
Read more in my blog posts about research at the Novartis Institutes for BioMedical Research here. Image courtesy of Pixabay, CC0 Public […]
Fat overload, immuno-oncology, and Alzheimer’s
Read my articles on Novartis’s research on liver disease (pg. 5), immuno-oncology (pg. 8), and Alzheimer’s (pg. 9) in the Basler Zeitung […]
Glitchy neural computations underlie a debilitating retinal disease
Nystagmus is a common retinal disease that manifests in two ways: an involuntary sideways wiggling of the eyes and, more insidiously, the […]














